UNIVERCELLS
Miriam Ramliden is a highly experienced scientist currently working at UNIVERCELLS since January 2024. Prior to this, Miriam held positions as Senior Scientist and Scientist at CATALOG from May 2022 to January 2024, and as Research Scientist II and Scientist I at DermBiont, Inc. from March 2021 to May 2022. Academic background includes a PhD in Molecular Microbiology from Tufts University, where Miriam was a PhD Candidate from September 2015 to February 2021, and a Master's degree in Infection Biology, along with a Bachelor's degree in Biology, both from Uppsala University. Additional experience includes work as a Junior Scientific Expert at the European Centre for Disease Prevention and Control and as a Microbiologist at the Public Health Agency of Sweden.
This person is not in any teams
UNIVERCELLS
1 followers
Univercells is a global life sciences company making biologics available to everyone. We operate as a campus of start-ups: five businesses solving different parts of the same puzzle - meeting global demand for bioproduction. Because it is not enough for a drug to exist. To change the world it must be accessible to everyone. Each division of affiliates operates a different part of the healthcare value chain, through a distinct business model: Exothera is a Contract Manufacturing and Development Organization (CDMO) for biologicals, mainly vaccines and viral vectors, with GMP production facilities in Belgium and offering process development and optimization services. https://exothera.world/. Unizima delivers international project management of technology transfer, alongside operational support services (quality, supply chain, digital) and bioproduction training programs, as well as care centers and diagnostics surveillance centers. https://unizima.com/. At Quantoom Biosciences, scientists, engineers and clinicians are committed to solve some of the biggest challenges facing mRNA-based vaccines and therapeutics by developing an end-to-end RNA Platform. This includes DNA and RNA manufacturing and formulation, along with critical reagent supply, from sequence to large-scale production. https://www.quantoom.com/. Thanks to a substantial knowledge of the pharmaceutical industry and a strong scientific background, RLM Consulting provides international regulatory affairs support at all stages of product development, from discovery research through preclinical and clinical testing, up to and beyond submission of the dossier for marketing authorization. http://www.rlmconsulting.be/.